|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| CURRENT ASSETS: | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Time deposits | |||||||||||||
| Accounts receivable | |||||||||||||
| Nonrelated Party | |||||||||||||
| Related party | |||||||||||||
| Assets held for sale | |||||||||||||
| Inventories | |||||||||||||
| Derivative assets | |||||||||||||
| Accrued revenue | |||||||||||||
| Restricted cash | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Short term investment | |||||||||||||
| Total current assets | |||||||||||||
| FIXED ASSETS: | |||||||||||||
| Vessels, net | |||||||||||||
| Advances for vessels | |||||||||||||
| Total fixed assets | |||||||||||||
| OTHER NON CURRENT ASSETS: | |||||||||||||
| Deferred finance charges, net | |||||||||||||
| Deferred financing costs | |||||||||||||
| Restricted cash | |||||||||||||
| Derivative assets | |||||||||||||
| Accrued revenue | |||||||||||||
| Other non current assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||
| CURRENT LIABILITIES: | |||||||||||||
| Curent portion | |||||||||||||
| Current portion of long-term debt, net | |||||||||||||
| Liability directly associated with assets held for sale | |||||||||||||
| Unearned revenue | |||||||||||||
| Trade accounts payable | |||||||||||||
| Related party | |||||||||||||
| Accrued liabilities | |||||||||||||
| Derivative liabilities | |||||||||||||
| Other financing liability | |||||||||||||
| Total current liabilities | |||||||||||||
| Long-term debt, net | |||||||||||||
| Unearned revenue | |||||||||||||
| Derivative liabilities | |||||||||||||
| Long-term portion | |||||||||||||
| Other liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| SHAREHOLDERS’ EQUITY: | |||||||||||||
| Common stock, $0.001 par value; 200,000,000 authorized, 105,288,996 and 102,259,402 issued and outstanding at December 31, 2024 and 2025, respectively | |||||||||||||
| Preferred stock, $0.01 par value; $20,000,000 authorized, 804,950 and 804,950 Series C Preferred Shares, 3,195,050 and 3,195,050 Series D Preferred Shares, issued and outstanding at December 31, 2024 and 2025, respectively | |||||||||||||
| Additional paid in capital | |||||||||||||
| Retained earnings | |||||||||||||
| Total shareholders’ equity | |||||||||||||
| Total liabilities and shareholders’ equity | |||||||||||||
| Common stock, par value (in USD per share) | |||||||||||||
| Ordinary shares authorized (in shares) | |||||||||||||
| Common Stock, Shares, Issued | |||||||||||||
| Common Stock, Shares, Outstanding | |||||||||||||
| Preferred stock, par value (in USD per share) | |||||||||||||
| Preference shares authorized (in shares) | |||||||||||||
Loading...
